Table 1.

Patient characteristics (n = 438) for patients who underwent myeloablative allogeneic transplantation at the University of Michigan from January 2000 to December 2005

Characteristic	Value
Median age, y (range)	42 (0-65)
Conditioning, no. (%)
Busulfan-based	298 (68)
BCNU-based	88 (20)
TBI-based	52 (12)
Donor source/match, no. (%)
6/6 related	247 (56)
5/6 related	20 (5)
6/6 unrelated	124 (28)
5/6 unrelated	47 (11)
Sex (donor → recipient), no. (%)
Male→ male	164 (37)
Female → male	101 (23)
Male→ female	107 (24)
Female → female	66 (15)
Diagnosis, no. (%)
Malignant	415 (95)
Nonmalignant	23 (5)
Status at transplantation, no. (%)
Standard risk	264 (61)
Advanced risk	151 (34)
Nonmalignant	23 (5)